Xuben Hou

2.4k total citations · 1 hit paper
86 papers, 1.9k citations indexed

About

Xuben Hou is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Xuben Hou has authored 86 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 27 papers in Oncology and 18 papers in Organic Chemistry. Recurrent topics in Xuben Hou's work include Histone Deacetylase Inhibitors Research (23 papers), Protein Degradation and Inhibitors (18 papers) and Protein Tyrosine Phosphatases (16 papers). Xuben Hou is often cited by papers focused on Histone Deacetylase Inhibitors Research (23 papers), Protein Degradation and Inhibitors (18 papers) and Protein Tyrosine Phosphatases (16 papers). Xuben Hou collaborates with scholars based in China, United States and Czechia. Xuben Hou's co-authors include Hao Fang, Xinying Yang, Yingkai Zhang, Jintong Du, Liang Tao, Xin Yu, Qiuju Han, Zhigang Tian, Peixiang Lan and Nan Lü and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Xuben Hou

83 papers receiving 1.8k citations

Hit Papers

Targeting histone deacetylases for cancer therapy: Trends... 2023 2026 2024 2025 2023 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting histone deacetylases for cancer therapy: Trends and challenges
    2023 111 citations Liang Tao, Xuben Hou et al. Acta Pharmaceutica Sinica B profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuben Hou China 24 1.3k 431 325 214 207 86 1.9k
Nam Doo Kim South Korea 32 1.8k 1.4× 454 1.1× 384 1.2× 230 1.1× 274 1.3× 102 2.9k
Xiangqian Kong China 24 1.2k 0.9× 257 0.6× 195 0.6× 176 0.8× 158 0.8× 77 1.9k
Luoting Yu China 29 1.6k 1.2× 1.1k 2.7× 476 1.5× 126 0.6× 152 0.7× 141 2.9k
Hong Ding China 26 1.7k 1.4× 311 0.7× 349 1.1× 166 0.8× 114 0.6× 80 2.3k
Haoliang Yuan China 21 697 0.6× 282 0.7× 312 1.0× 196 0.9× 129 0.6× 71 1.2k
Zunnan Huang China 26 1.6k 1.2× 264 0.6× 320 1.0× 333 1.6× 193 0.9× 116 2.6k
Mark R. Player United States 28 1.0k 0.8× 924 2.1× 304 0.9× 129 0.6× 264 1.3× 97 2.5k
William B. Mattes United States 27 1.5k 1.2× 229 0.5× 283 0.9× 146 0.7× 105 0.5× 74 2.2k
Pankaj Kumar Singh India 30 743 0.6× 772 1.8× 273 0.8× 213 1.0× 143 0.7× 127 2.3k

Countries citing papers authored by Xuben Hou

Since Specialization
Citations

This map shows the geographic impact of Xuben Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuben Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuben Hou more than expected).

Fields of papers citing papers by Xuben Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuben Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuben Hou. The network helps show where Xuben Hou may publish in the future.

Co-authorship network of co-authors of Xuben Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Xuben Hou. A scholar is included among the top collaborators of Xuben Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuben Hou. Xuben Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xue, Yue Zhou, Xinying Yang, et al.. (2024). Simultaneous inhibition of FLT3 and HDAC by novel 6-ethylpyrazine-2-Carboxamide derivatives provides therapeutic advantages in acute myelocytic leukemia. European Journal of Medicinal Chemistry. 279. 116847–116847. 4 indexed citations
2.
Hou, Xuben, et al.. (2024). Targeting active RAS with molecular glue. SHILAP Revista de lepidopterología. 2. 100047–100047. 2 indexed citations
3.
Lu, Hao, et al.. (2024). Recent Development of CDK2 Inhibitors as Anticancer Drugs: An Update (2015–2023). SHILAP Revista de lepidopterología. 6(3). e195–e220. 1 indexed citations
4.
Zhao, Yunpeng, et al.. (2023). Design, synthesis and bioactivity evaluations of 8-substituted-quinoline-2-carboxamide derivatives as novel histone deacetylase (HDAC) inhibitors. Bioorganic & Medicinal Chemistry. 85. 117242–117242. 7 indexed citations
5.
Hou, Xuben, Ming Zhang, Minghui Song, et al.. (2023). Characterization of an allosteric inhibitor of fungal-specific C-24 sterol methyltransferase to treat Candida albicans infections. Cell chemical biology. 30(5). 553–568.e7. 11 indexed citations
6.
Qiu, Xueting, Xuben Hou, Yue Yang, et al.. (2023). An in-line method for high-throughput screening of protein tyrosine phosphatase receptor type O inhibitors by capillary electrophoresis based on electrophoretically mediated microanalysis. Journal of Chromatography A. 1713. 464511–464511. 4 indexed citations
7.
Sun, Jianfeng, Xue Li, Xuben Hou, et al.. (2022). Structural basis of human SNAPc recognizing proximal sequence element of snRNA promoter. Nature Communications. 13(1). 6871–6871. 8 indexed citations
8.
Chang, Wenqiang, Ming Zhang, Hongbo Zheng, et al.. (2022). Inhibition of fungal pathogenicity by targeting the H 2 S-synthesizing enzyme cystathionine β-synthase. Science Advances. 8(50). eadd5366–eadd5366. 11 indexed citations
9.
Liang, Xiao, Xuben Hou, & Hao Fang. (2021). Structure, Function and Modulation of Striatal-enriched Protein Tyrosine Phosphatase (STEP). Current Medicinal Chemistry. 28(37). 7714–7728. 3 indexed citations
10.
Hou, Xuben, Jintong Du, & Hao Fang. (2021). PTPRO is a therapeutic target and correlated with immune infiltrates in pancreatic cancer. Journal of Cancer. 12(24). 7445–7453. 7 indexed citations
11.
Liu, Meng, et al.. (2021). Strategies to overcome drug resistance using SHP2 inhibitors. Acta Pharmaceutica Sinica B. 11(12). 3908–3924. 36 indexed citations
12.
Tao, Liang, et al.. (2021). Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors. European Journal of Medicinal Chemistry. 221. 113526–113526. 14 indexed citations
13.
Yang, Yue, et al.. (2020). Enantioseparation of lysine derivatives on amylose tris (3, 5-dimethylphenylcarbamate) as chiral stationary phase with high separation factor. Journal of Chromatography A. 1632. 461598–461598. 13 indexed citations
14.
Hou, Xuben, Jin‐Peng Sun, Lin Ge, et al.. (2020). Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed cryptic pockets. European Journal of Medicinal Chemistry. 190. 112131–112131. 5 indexed citations
15.
Li, Kangshuai, Xuben Hou, Ruirui Li, et al.. (2019). Identification and structure–function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22. Journal of Biological Chemistry. 294(21). 8653–8663. 12 indexed citations
16.
Chen, Chen, Xuben Hou, Guohua Wang, et al.. (2017). Design, synthesis and biological evaluation of quinoline derivatives as HDAC class I inhibitors. European Journal of Medicinal Chemistry. 133. 11–23. 36 indexed citations
17.
Hou, Xuben, et al.. (2015). Design, synthesis and biological evaluation of 3-aryl-rhodanine benzoic acids as anti-apoptotic protein Bcl-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(22). 5265–5269. 23 indexed citations
18.
Pan, Chang, Hongda Liu, Zheng Gong, et al.. (2013). Cadmium is a potent inhibitor of PPM phosphatases and targets the M1 binding site. Scientific Reports. 3(1). 2333–2333. 58 indexed citations
19.
Hou, Xuben, Jintong Du, Hao Fang, & Minyong Li. (2011). 3D-QSAR Study on a Series of Bcl-2 Protein Inhibitors Using Comparative Molecular Field Analysis. Protein and Peptide Letters. 18(5). 440–449. 14 indexed citations
20.
Hou, Xuben, et al.. (1997). Properties of bacteriorhodopsin's response to modulated light.. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 24(5). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nam Doo Kim Breakdown of academic impact, for papers by Xiangqian Kong Breakdown of academic impact, for papers by Luoting Yu Breakdown of academic impact, for papers by Hong Ding Breakdown of academic impact, for papers by Haoliang Yuan Breakdown of academic impact, for papers by Zunnan Huang Breakdown of academic impact, for papers by Mark R. Player Breakdown of academic impact, for papers by William B. Mattes Breakdown of academic impact, for papers by Pankaj Kumar Singh
Rankless by CCL
2026